A Study of TNB-383B in Participants With Relapsed or Refractory Multiple Myeloma

NCT03933735 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

220

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: TNB-383B

Sponsor

AbbVie